Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Air Lease Pref A | AL-A | Jan 13, 2025 | 25.18 | 0.00 |
Air Products And Chemicals | APD | Jan 13, 2025 | 301.74 | +2.95 |
Air T | AIRTP | Jan 13, 2025 | 17.26 | -1.03 |
Air T | AIRT | Jan 13, 2025 | 19.08 | -4.07 |
Air Transport Services Group | ATSG | Jan 13, 2025 | 22.06 | +0.09 |
Airbnb A | ABNB | Jan 13, 2025 | 128.85 | -0.60 |
Airgain | AIRG | Jan 13, 2025 | 6.00 | -7.12 |
AirJoule Technologies A | AIRJ | Jan 13, 2025 | 7.87 | +0.64 |
AirNet Technology ADR | ANTE | Jan 13, 2025 | 0.44 | -5.86 |
AirSculpt Technologies | AIRS | Jan 13, 2025 | 4.79 | -19.90 |
Airship AI A | AISP | Jan 13, 2025 | 4.17 | -9.74 |
AIX ADR | AIFU | Jan 13, 2025 | 0.34 | 0.00 |
Akamai Technologies | AKAM | Jan 13, 2025 | 89.61 | +0.76 |
Akanda | AKAN | Jan 13, 2025 | 1.63 | +4.49 |
Akari Therapeutics ADR | AKTX | Jan 13, 2025 | 1.21 | -0.41 |
Akebia Therapeutics | AKBA | Jan 13, 2025 | 1.87 | +6.86 |
Akero Therapeutics | AKRO | Jan 13, 2025 | 22.63 | -8.90 |
Akoustis Technologies | AKTS | Jan 13, 2025 | 0.04 | 0.00 |
Akoya BioSciences | AKYA | Jan 13, 2025 | 2.93 | -3.30 |
Akso Health ADR | AHG | Jan 13, 2025 | 1.30 | +4.00 |
Alamo Group | ALG | Jan 13, 2025 | 176.40 | +2.02 |
Alamos Gold | AGI | Jan 13, 2025 | 19.16 | -1.79 |
Alarm.com | ALRM | Jan 13, 2025 | 59.61 | +0.27 |
Alarum Technologies ADR | ALAR | Jan 13, 2025 | 10.30 | -3.01 |
Alaska Air Group | ALK | Jan 13, 2025 | 66.47 | -2.51 |
Alaunos Therapeutics | TCRT | Jan 13, 2025 | 1.74 | +2.35 |
Albany International | AIN | Jan 13, 2025 | 79.78 | +1.96 |
Albemarle | ALB | Jan 13, 2025 | 91.51 | +5.76 |
Albemarle ADR A Pref | ALB-A | Jan 13, 2025 | 43.10 | +4.33 |
Albertsons Companies A | ACI | Jan 13, 2025 | 20.66 | +3.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.